BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
P/S ratio for BioNexus Gene Lab Corp. (BGLC)
P/S ratio as of 2023: 0.86
According to BioNexus Gene Lab Corp.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.86. At the end of 2022 the company had a P/S ratio of 1.25.
P/S ratio history for BioNexus Gene Lab Corp. from 2016 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 0.86 |
| 2022 | 1.25 |
| 2021 | 2.27 |
| 2020 | 1.73 |
| 2019 | 23.24 |
| 2018 | 10.67 |
| 2017 | 23.68 |
| 2016 | 0.00 |